AstraZeneca (Distribution rights of Foscavir) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

AstraZeneca (Distribution rights of Foscavir) General Information

Description

The global marketing and distribution rights of antiviral agent. The antiviral agent is licensed for the treatment of cytomegalovirus (CMV) retinitis in HIV patients and acyclovir-resistant mucocutaneous herpes simplex virus (HSV) infections in immunocompromised patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Commercial Services
Pharmaceuticals
Acquirer
Primary Office
  • 2 Kingdom Street
  • London W2 6BD
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AstraZeneca (Distribution rights of Foscavir) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AstraZeneca (Distribution rights of Foscavir)‘s full profile, request access.

Request a free trial

AstraZeneca (Distribution rights of Foscavir) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AstraZeneca (Distribution rights of Foscavir)‘s full profile, request access.

Request a free trial